Clinical Trial Update: Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A completed phase 1/2 trial evaluating temozolomide and thalidomide in patients with stage III or stage IV melanoma, including intraocular and cutaneous melanom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Intraocular Melanoma

Drugs mentioned

• Temozolomide (Temodar) (Temozolomide)
• Thalidomide (Thalomid) (thalidomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Intraocular Melanoma, Melanoma (Skin) | Phase 1, Phase 2 | Status: COMPLETED